Skip to content

What is the use of Mirabel Tablet? Understanding Mirabegron (Myrbetriq) for Overactive Bladder

4 min read

According to MedlinePlus, the active ingredient mirabegron, often marketed under the brand name Myrbetriq, is used to treat overactive bladder. While the term 'Mirabel Tablet' may lead to confusion with a taste-enhancing product, in a medical context, it is most likely a reference to Myrbetriq, the medication used to treat symptoms such as urinary urgency, frequency, and leakage. This article clarifies the actual use of mirabegron and distinguishes it from the similarly named, non-medical alternative.

Quick Summary

Mirabegron (brand name Myrbetriq) is a prescription medication primarily used to treat the symptoms of overactive bladder (OAB) in adults, and sometimes neurogenic detrusor overactivity (NDO) in children. It works by relaxing the bladder muscles, which increases the bladder's capacity to hold urine.

Key Points

  • Mirabegron vs. Mirabel: The term 'Mirabel Tablet' likely refers to Myrbetriq (mirabegron), a prescription medication for overactive bladder, not a taste-enhancing supplement.

  • OAB Treatment: Mirabegron is used to treat symptoms of an overactive bladder (OAB) in adults, including urinary urgency, frequency, and incontinence.

  • Mechanism: It works by relaxing the bladder muscles, allowing the bladder to hold more urine and reducing the urge to urinate.

  • Side Effects: Common side effects include headache, hypertension, UTIs, and constipation, while serious effects like severe hypertension and urinary retention are possible but less common.

  • Contraindications: Mirabegron is not recommended for patients with severe, uncontrolled hypertension or severe kidney or liver disease.

  • Alternative to Anticholinergics: As a beta-3 agonist, mirabegron offers an alternative to older antimuscarinic medications, potentially with a better side-effect profile for some patients.

  • Long-term Use: Mirabegron is generally taken long-term to manage OAB symptoms, and patients should not stop taking it without consulting their doctor.

In This Article

Before taking any medication, including mirabegron (Myrbetriq), it is crucial to consult with a healthcare provider. Information provided here is for general knowledge and should not be considered medical advice.

What is Mirabegron (Myrbetriq)?

Mirabegron is a prescription medication belonging to a class of drugs called beta-3 adrenergic agonists. Its most common brand name is Myrbetriq. Unlike older overactive bladder (OAB) medications known as antimuscarinics, mirabegron operates on a different pathway, offering an alternative for patients who cannot tolerate or do not respond well to other treatments. It is available as extended-release tablets and an extended-release oral suspension.

Therapeutic Uses of Mirabegron

Mirabegron is prescribed for specific urinary conditions to improve bladder control and reduce disruptive symptoms. Its primary uses include:

  • Overactive Bladder (OAB) in adults: Mirabegron is used alone or in combination with other medications, such as solifenacin, to treat OAB. OAB causes symptoms like a sudden, compelling urge to urinate (urgency), urinating more frequently than normal, and accidental leakage or incontinence.
  • Neurogenic Detrusor Overactivity (NDO) in children: For children aged 3 years and older who have a bladder control condition related to a nervous system problem, mirabegron can help manage symptoms.

The mechanism of action

Mirabegron works by relaxing the detrusor muscle, the smooth muscle that surrounds the bladder. When this muscle relaxes, the bladder can hold a larger volume of urine before signaling the need to urinate. This reduces the urgency and frequency of urination episodes.

Dosage and administration

The appropriate dosage of mirabegron is determined by a healthcare professional based on individual patient needs, response to treatment, and other health factors. It is crucial to follow a doctor's instructions precisely regarding how much medication to take and how often.

  • Administration: The extended-release tablets should be swallowed whole with water and not crushed, divided, or chewed. It can be taken with or without food. Consistency is key, so taking it at the same time each day as prescribed is often recommended.
  • Special populations: Dosage adjustments may be necessary for patients with moderate hepatic (liver) or severe renal (kidney) impairment. The medication is not recommended for those with severe hepatic impairment or end-stage renal disease.

Common and serious side effects

Mirabegron can cause side effects, which vary in severity. Patients should discuss potential risks with their healthcare provider.

Common side effects:

  • Headache
  • Elevated blood pressure (hypertension)
  • Urinary tract infection (UTI)
  • Nasopharyngitis (symptoms of the common cold)
  • Constipation
  • Dizziness
  • Increased heart rate

Serious side effects:

  • High blood pressure: Mirabegron can increase blood pressure, and periodic monitoring is recommended, especially for patients with pre-existing hypertension.
  • Urinary retention: This is the inability to completely empty the bladder, a rare but possible side effect. The risk is higher in individuals with bladder outlet obstruction or when mirabegron is combined with antimuscarinic medications.
  • Angioedema: This is a severe allergic reaction involving swelling of the face, lips, tongue, or throat and requires immediate medical attention.

Mirabegron vs. Anticholinergic Medications

For overactive bladder, mirabegron offers an alternative to older anticholinergic drugs like tolterodine or oxybutynin. The choice of medication depends on the patient's specific needs, comorbidities, and tolerance for side effects.

Feature Mirabegron (Myrbetriq) Anticholinergic Medications (e.g., Oxybutynin)
Mechanism of Action Beta-3 adrenergic agonist; relaxes bladder muscle to increase storage capacity. Muscarinic receptor antagonist; blocks nerve signals that cause bladder muscle contractions.
Common Side Effects Headache, elevated blood pressure, constipation, UTI. Dry mouth, constipation, blurry vision, confusion, sleepiness.
Cardiovascular Effects Can increase blood pressure and heart rate; monitor closely in hypertensive patients. Generally fewer cardiovascular side effects, but some can affect heart rhythm.
Cognitive Impact Not known to cause cognitive issues like confusion, making it potentially safer for older adults. Can cause or worsen cognitive impairment, especially in older adults.
Bladder Outlet Obstruction Caution advised; higher risk of urinary retention in combination with antimuscarinics. Caution advised; risk of urinary retention.

The 'Mirabel' confusion: Not a medical tablet

It is important to note that the term 'Mirabel Tablet' may be a mistaken reference to a non-medical product. User reviews indicate that "MiraBurst" is a brand of taste-enhancing tablets made from the miracle berry (Synsepalum dulcificum). This product temporarily modifies the perception of sour and acidic foods, making them taste sweet. It is sold as a dietary supplement and has no medical function related to bladder health. If you are experiencing OAB symptoms, you should consult a doctor, not self-medicate with dietary supplements.

Conclusion

While the term 'Mirabel Tablet' can be confusing, in a medical context, it most likely refers to the medication mirabegron, sold under the brand name Myrbetriq. This beta-3 adrenergic agonist is a crucial treatment option for adults with overactive bladder and certain children with neurogenic detrusor overactivity. It works by relaxing the bladder muscle to alleviate symptoms like urgency, frequency, and incontinence. As with any prescription drug, it is essential to discuss mirabegron with a healthcare provider to determine the appropriate course of treatment and monitor for potential side effects and interactions. Always seek professional medical advice before starting, stopping, or changing a medication. For further details on mirabegron, a valuable resource is the DailyMed service provided by the U.S. National Library of Medicine.

Frequently Asked Questions

The primary medical use of mirabegron (Myrbetriq) is to treat the symptoms of overactive bladder (OAB) in adults, which include urgency, frequency, and urinary incontinence.

Mirabegron is a beta-3 adrenergic agonist that relaxes the bladder muscle, whereas anticholinergic medications block nerve signals that trigger bladder contractions. Mirabegron may offer a better side-effect profile, particularly regarding cognitive effects in older adults.

Common side effects include elevated blood pressure, urinary tract infections (UTIs), headaches, nasopharyngitis, and constipation.

Myrbetriq should not be taken by individuals with severe, uncontrolled high blood pressure, severe kidney or liver disease, or a known hypersensitivity to mirabegron.

Yes, mirabegron can cause an increase in blood pressure. Your doctor will likely monitor your blood pressure periodically while you are taking this medication.

Urinary retention (trouble emptying the bladder) is a rare but possible side effect of Myrbetriq. The risk is higher for those with bladder outlet obstruction or when the medication is combined with other antimuscarinic drugs.

While some improvements may be felt within a few weeks, it can take 8 weeks or longer to experience the full benefits of mirabegron.

Yes, mirabegron is also approved to treat neurogenic detrusor overactivity (NDO) in children aged 3 years and older.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.